This article is from the source 'rtcom' and was first published or seen on . It last changed over 40 days ago and won't be checked again for changes.
You can find the current article at its original source at https://www.rt.com/news/523416-eu-second-legal-action-astrazeneca-covid/
The article has changed 3 times. There is an RSS feed of changes available.
| Version 0 | Version 1 |
|---|---|
| EU to hit AstraZeneca with second lawsuit over Covid-19 vaccine delivery delays, spokesperson says | EU to hit AstraZeneca with second lawsuit over Covid-19 vaccine delivery delays, spokesperson says |
| (4 months later) | |
| The European Commission will take further legal action against AstraZeneca over delayed shipments of its Covid-19 jabs earlier this year, a spokesperson for the EU’s executive branch has said. | The European Commission will take further legal action against AstraZeneca over delayed shipments of its Covid-19 jabs earlier this year, a spokesperson for the EU’s executive branch has said. |
| “Tomorrow, the case against AstraZeneca on the merits [of the proposed lawsuit] will be introduced before the Belgian court,” the spokesperson told a news briefing on Monday. | “Tomorrow, the case against AstraZeneca on the merits [of the proposed lawsuit] will be introduced before the Belgian court,” the spokesperson told a news briefing on Monday. |
| This second round of legal action against the Anglo-Swedish drugs manufacturer is mostly procedural, according to Reuters, but could allow the bloc to seek financial penalties. | This second round of legal action against the Anglo-Swedish drugs manufacturer is mostly procedural, according to Reuters, but could allow the bloc to seek financial penalties. |
| The Commission’s first legal action against AstraZeneca was launched last month, after it accused the company of a “breach” of the advance purchase agreement it signed with the EU for supplies of its vaccine. | The Commission’s first legal action against AstraZeneca was launched last month, after it accused the company of a “breach” of the advance purchase agreement it signed with the EU for supplies of its vaccine. |
| In a statement at the time, the company said it regretted the Commission’s action and denied the claims it had breached its agreement, dismissing the suit as being “without merit.” | In a statement at the time, the company said it regretted the Commission’s action and denied the claims it had breached its agreement, dismissing the suit as being “without merit.” |
| In the second quarter of 2021, AstraZeneca had originally agreed to supply the EU with 180 million doses of the vaccine it developed in partnership with the University of Oxford. | In the second quarter of 2021, AstraZeneca had originally agreed to supply the EU with 180 million doses of the vaccine it developed in partnership with the University of Oxford. |
| However, Commission President Ursula von der Leyen said in March the company would be able to deliver only 70 million doses during this period. | However, Commission President Ursula von der Leyen said in March the company would be able to deliver only 70 million doses during this period. |
| AstraZeneca cited production issues at its plant in Belgium as a reason for the shortfall. | AstraZeneca cited production issues at its plant in Belgium as a reason for the shortfall. |
| On Monday, the Commission spokesperson said that in the first quarter of this year, AstraZeneca had delivered around 30 million doses, and in the second quarter, it had “announced” the delivery of 70 million doses. | On Monday, the Commission spokesperson said that in the first quarter of this year, AstraZeneca had delivered around 30 million doses, and in the second quarter, it had “announced” the delivery of 70 million doses. |
| He said the court case was to make sure the EU can obtain the “delivery of the doses we are entitled to,” but refused to comment further in light of the legal proceedings. | He said the court case was to make sure the EU can obtain the “delivery of the doses we are entitled to,” but refused to comment further in light of the legal proceedings. |
| Like this story? Share it with a friend! | Like this story? Share it with a friend! |
| Dear readers and commenters, | |
| We have implemented a new engine for our comment section. We hope the transition goes smoothly for all of you. Unfortunately, the comments made before the change have been lost due to a technical problem. We are working on restoring them, and hoping to see you fill up the comment section with new ones. You should still be able to log in to comment using your social-media profiles, but if you signed up under an RT profile before, you are invited to create a new profile with the new commenting system. | |
| Sorry for the inconvenience, and looking forward to your future comments, | |
| RT Team. |